ADAMAX
ADAMAX is a proprietary research peptide preparation supplied strictly for in-vitro laboratory investigation. It is intended for use by qualified researchers exploring peptide chemistry, receptor-binding assays, and comparative signaling models. Every vial is lyophilized under controlled conditions and independently verified at greater than 99% purity for reproducible experimental workflows.
Adamax is chemically documented as Ac-MEHFPGP AG-NH2. It enhances the foundational structure of Semax by attaching two distinct molecular modifications: [1, 2, 3]
- N-Terminal Acetylation: An acetyl group is added to shield the peptide from rapid enzymatic breakdown in the blood.
- C-Terminal Adamantane Group: It incorporates an adamantane group, a structural addition shared with the experimental neurogenic peptide P21. [1, 2, 3]
This specific combination creates a molecule that easily crosses the blood-brain barrier (BBB) and remains stable in the body significantly longer than standard Semax.]
Purported Mechanisms of Action
In preclinical models, Adamax exhibits distinct neurotrophic and stimulatory behaviors:
- BDNF Upregulation: It increases levels of Brain-Derived Neurotrophic Factor (BDNF), a critical protein responsible for neuroplasticity, memory formation, and the survival of existing brain cells. [1, 2]
- TrkB Receptor Sensitivity: It enhances the sensitivity of hippocampal TrkB receptors, which maximizes the cognitive impact of the body’s natural BDNF pools. [1]
- Neurotransmitter Modulation: Research suggests it subtly interacts with dopaminergic and serotonergic systems, helping to elevate motivation and cognitive clarity under physical or mental stress. [1]
- Physical Endurance: Anecdotal user reports and preliminary cell work suggest it significantly improves cellular stamina and athletic recovery compared to its parent compounds. [1]
Regulatory Status and Safety Profiles
- Not FDA Approved: Adamax is not approved by the FDA or any major Western regulatory body for human use. It is classified strictly as an unapproved “designer drug” and research chemical. [1, 2]
- Compounding Restrictions: Unlike other peptides undergoing active FDA compounding reviews, Adamax has never been on an approved bulks compounding list. It is entirely prohibited from being manufactured by licensed pharmacies. [1, 2]
- The Black Market Threat: Because it lacks clinical manufacturing oversight, gray-market versions sold online as nasal sprays or injectables run an exceptionally high risk of containing heavy metals, chemical impurities, or incorrect dosages. [1]
- Zero Human Trials: There are absolutely no completed human clinical trials evaluating the safety, efficacy, or long-term toxicological side effects of Adamax.
If you are researching this designer peptide, let me know:
- Are you exploring it for cognitive enhancement (nootropic) or athletic stamina?
- Would you like to see how it compares to its parent compound, Semax?
- Are you interested in safer, FDA-approved cognitive therapies?
Reviews
There are no reviews yet.